证券日报网讯1月13日，中欣氟材（002915）在互动平台回答投资者提问时表示，截至2026年1月9日公 司股东人数为66，990户。 ...

Group 1 - The company, Zhejiang Zhongxin Fluorine Material Co., Ltd., has recently obtained a "Pesticide Production License" issued by the Zhejiang Provincial Department of Agriculture and Rural Affairs [1] - The license allows the company to commercially produce the pesticide "Avermectin," enhancing its product structure and core competitiveness [1] - The license is valid from January 6, 2026, to January 5, 2031, marking a significant milestone for the company's long-term development [1][4] Group 2 - The acquisition of the pesticide production license is expected to have a positive impact on the company's future operations, although it will not significantly affect the company's performance in the short term [1]

Group 1 - China Shipbuilding Defense expects a net profit of 940 million to 1.12 billion yuan for 2025, an increase of 149.61% to 196.88% year-on-year [1] - China First Heavy Industries has only undertaken a small number of related accessory projects and has not generated revenue from them [2] - Huanyu Electronics plans to invest 30 million yuan in a private equity fund focused on AI and emerging industries [3] Group 2 - Zhixiang Jintai's GR1803 injection has been included in the priority review list by the National Medical Products Administration [4] - JianKai Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [5] - Debon Holdings will continue to suspend trading from January 12 due to significant matters being planned [6] Group 3 - South Network Technology's shareholder intends to transfer 847.05 million shares, accounting for 1.50% of the total share capital [7] - Hengrui Medicine has received approval for clinical trials of four drugs [8] - Daotong Technology expects a net profit of 900 million to 930 million yuan for 2025, a year-on-year increase of 40.42% to 45.10% [10] Group 4 - Betta Pharmaceuticals has invested 50 million yuan to acquire a 20% stake in Hangzhou Zhixing Pharmaceutical [11] - Tianyu Biology reported a 10.38% year-on-year decline in cumulative sales revenue for 2025 [12] - Lifang Pharmaceutical's subsidiary has obtained a drug registration certificate for a pain relief product [13] Group 5 - R&F Properties reported a total sales revenue of approximately 14.21 billion yuan for 2025 [14] - Wanfu Biology expects a net profit decline of 87.71% to 91.81% for 2025 [15] - Dazhi expects a negative net profit for 2025 [16] Group 6 - Dongzhu Ecology is negotiating to terminate the acquisition of control over a satellite communication company [17] - Baotai has received a milestone payment of 10 million USD from Hikma Pharmaceuticals [18] - Huace Navigation expects a net profit of 670 million to 690 million yuan for 2025, a year-on-year increase of 14.84% to 18.27% [19] Group 7 - Shenzhen Gas reported a net profit decline of 3.45% for 2025 [20] - Baogang Co. plans to adjust the price of rare earth concentrate for Q1 2026 to 26,834 yuan per ton [21] - Jiuding Investment expects to report a loss for 2025 [22] Group 8 - Shanghai Pharmaceuticals has received a drug registration certificate for a treatment for myasthenia gravis [23] - Hualan Biological plans to acquire a 35% stake in Guangfeng Capsule [24] - Ruina Intelligent plans to invest 169.9 million yuan in a new R&D production base for heat pumps [25] Group 9 - Wantong Development expects to report a loss for 2025 [26] - Xianghe Industrial has completed the purchase of a 5% stake in Hezhixiang Technology [27] - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Commission [28] Group 10 - Xiaoming Co. reported a 37.07% year-on-year decline in chicken product sales revenue for December 2025 [29] - Luokai Co. won a procurement project from State Grid Fujian Power worth approximately 48.2 million yuan [30] - Minhe Co. reported a 65.22% year-on-year increase in the sales of commodity chick seedlings for December 2025 [31] Group 11 - Zhenghai Biological has obtained a registration certificate for calcium silicate bio-ceramic materials [32] - Three Gorges Energy reported a 5.99% year-on-year increase in cumulative total power generation for 2025 [33] - Huisheng Biological expects a net profit of 235 million to 271 million yuan for 2025 [34] Group 12 - Maihe Co. announced the release of the detention measures against its chairman [35] - Wandong's Alzheimer's project has been included in a national major special project for innovative drug development [36] - Kangxin New Materials plans to transfer forest land assets with a book value of 1.203 billion yuan [37] Group 13 - Greenland Holdings expects a net loss of 16 billion to 19 billion yuan for 2025 [39] - Zhongxin Fluorine Materials has obtained a pesticide production license [40]

Group 1 - The company Zhongxin Fluorine Materials (002915) has recently obtained a "Pesticide Production License" issued by the Zhejiang Provincial Department of Agriculture and Rural Affairs [1] - This is the first time the company has acquired a "Pesticide Production License," which provides qualification assurance for the commercial production of its product, oxazolone [1]

Core Viewpoint - Zhongxin Fluorine Materials (002915.SZ) has recently obtained the "Pesticide Production License" issued by the Zhejiang Provincial Department of Agriculture and Rural Affairs, marking the company's first acquisition of such a license, which provides qualification assurance for the commercial production of its product, chlorothalonil [1] Group 1 - The acquisition of the pesticide production license will optimize the company's product structure and positively impact its long-term development [1] - This license enhances the company's core competitiveness [1] - The impact of this license on the company's future production and operations is expected to be positive, although it will not significantly affect the company's performance in the short term [1]

格隆汇1月9日丨中欣氟材(002915.SZ)公布，近日取得了浙江省农业农村厅颁发的《农药生产许可 证》，本次系公司首次取得《农药生产许可证》，为公司噁霉灵产品进行商业化生产提供了资质保障， 有利于优化公司产品结构，对公司长远发展有着积极的推动作用，进一步增强公司的核心竞争力。上述 农药生产许可证的取得对公司未来生产经营将产生积极影响，短期内不会对公司业绩产生重大影响，敬 请投资者注意投资风险。 ...

证券代码：002915 证券简称：中欣氟材 公告编号：2026-001 浙江中欣氟材股份有限公司 关于公司取得《农药生产许可证》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江中欣氟材股份有限公司（以下简称"公司"）于近日取得了浙江省农业 农村厅颁发的《农药生产许可证》，现将相关信息公告如下： 统一社会信用代码：91330600723626031R 法定代表人：徐建国 住所：浙江省绍兴市上虞区杭州湾上虞经济技术开发区经十三路 5 号 生产地址：浙江省绍兴市上虞区杭州湾上虞经济技术开发区经十三路 5 号 生产范围：噁霉灵 首次批准日期：2026 年 01 月 06 日 有效期至：2031 年 01 月 05 日 二、对公司的影响及风险提示 一、《农药生产许可证》的基本信息 编号：农药生许（浙）0103 生产企业名称：浙江中欣氟材股份有限公司 三、备查文件 1、《农药生产许可证》。 特此公告。 浙江中欣氟材股份有限公司董事会 2026 年 1 月 9 日 本次系公司首次取得《农药生产许可证》，为公司噁霉灵产品进行商业化 生产提供了资质保障，有利于优化公 ...

Core Viewpoint - The company has obtained a pesticide production license for the product "Avermectin," which is expected to enhance its competitive edge and optimize product structure, although it will not have a significant short-term impact on performance [1] Group 1 - The company received the pesticide production license from the Zhejiang Provincial Department of Agriculture and Rural Affairs, with the license number being "农药生许（浙）0103" [1] - The production scope of the license includes "Avermectin," with the first approval date set for January 6, 2026, and a validity period until January 5, 2031 [1] - This is the company's first acquisition of such a license, providing qualification assurance for the commercial production of Avermectin [1] Group 2 - The license is expected to positively impact the company's future production and operations by enhancing its core competitiveness [1] - The short-term financial performance is not anticipated to be significantly affected by this development [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002915 证券简称：中欣氟材 公告编号：2025-089 浙江中欣氟材股份有限公司关于2025年度以简易程序向特定对象发行股票预案及相关文件修订说明的公 告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 浙江中欣氟材股份有限公司（以下简称"公司"）于2025年12月31日召开第七届董事会第五次会议，审议 通过了《关于公司2025年度以简易程序向特定对象发行股票预案（二次修订稿）的议案》等议案，并对 本次以简易程序向特定对象发行股票的相关文件进行了修订。具体情况如下： 根据公司2024年年度股东会的授权，本次发行预案及相关文件的修订无需提交公司股东会审议。本次发 行预案及相关文件主要修订情况如下： ■ 具体内容详见公司同日在《证券时报》《证券日报》《中国证券报》《上海证券报》和巨潮资讯网 （http://www.cninfo.com.cn）披露的《浙江中欣氟材股份有限公司2025年度以简易程序向特定对象发行 股票预案（二次修订稿）》《浙江中欣氟材股份有限公司2025年度以简易程序向特定对象发行股票 ...

每经AI快讯，中欣氟材1月4日晚间发布公告称，公司第七届董事会第五次会议于2025年12月31日在杭 州湾上虞经济技术开发区经十三路五号浙江中欣氟材股份有限公司研发中心一楼视频会议室以现场结合 通讯表决的方式召开。会议审议了《关于公司2025年度以简易程序向特定对象发行股票方案论证分析报 告的议案》等文件。 （记者 张明双） 每经头条（nbdtoutiao）——AI泡沫破灭？美股下跌20%？量子计算颠覆加密货币？金价涨破1万美元？ 2026年华尔街和科技圈十大预测来了 ...